Mulmit

SANGAMO THERAPEUTICS, INCSANGAMO THERAPEUTICS, INC

SGMOQ US

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3139,552,000-121,239,000-122,932,000-0.44
2024-12-3157,800,000-103,969,000-97,941,000-0.49
2023-12-31176,232,000-274,005,000-257,831,000-1.48
2022-12-31111,299,000-201,281,000-192,278,000-1.25
2021-12-31110,701,000-183,337,000-178,286,000-1.23
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.